About the Company
Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GNMX News
Genomic Medicine Market Forecasted to Expand at 17% CAGR by 2032
According to a recent report by Market.us, the Global Genomic Medicine Market size is expected to be worth around USD 123.9 Billion by 2032 from USD 31.4 Billion in 2023, growing at a CAGR of 17% ...
Garry Arthur Neil's Net Worth
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $38.1 ...
Access to genomic medicine illustrates precision medicine’s delicate future
Japan – As genomics and precision medicine advances open new avenues for personalized treatments to replace the conventional one-size-fits-all model, who will actually benefit from them?
Global Genomic Medicine Collaborative (G2MC)
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
The next steps for genomic medicine: challenges and opportunities for the developing world
This is a historical moment on the path to genomic medicine — the point at which theory is about to be translated into practice. We have previously described human genome variation studies ...
Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and ...
Investment fuels AI-driven development of breakthrough genomic medicines
“Genomic medicine is a rapidly growing space in which ... including Erenis (sold to SFR – May 2007), Bizanga (sold to Cloudmark Inc – June 2010), 3D+ (sold to Heico Corp – April 2011 ...
Do Physicians Think Genomic Medicine Will Be Useful for Patient Care?
However, the use of genomic information, so-called genomic medicine, in routine clinical care, has been slow in comparison to the growth in genomic discovery. The uptake of genomic technology into ...
EDITORIAL: Bill on genomic medicine should secure quality of new services
A bill to promote genomic medicine, which involves using people’s genomic information as part of their clinical care, has passed a Lower House committee and is set to be enacted after ...
OMIC Singular Genomics Systems, Inc.
Singular Genomics ... Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine.
Bionano Genomics Inc BNGO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Do Physicians Think Genomic Medicine Will Be Useful for Patient Care?
[33] Educational efforts, particularly focused on the practical aspects of genomic medicine, may find a willing audience among physicians across disciplines. It is important to note that barriers ...
Loading the latest forecasts...